OMCL | Omnicell, Inc.

Index- P/E- EPS (ttm)-0.41 Insider Own0.80% Shs Outstand44.89M Perf Week-2.35%
Market Cap3.21B Forward P/E28.98 EPS next Y2.49 Insider Trans-4.95% Shs Float44.02M Perf Month7.72%
Income-17.60M PEG- EPS next Q0.29 Inst Own102.80% Short Float / Ratio6.54% / 6.91 Perf Quarter40.24%
Sales1.27B P/S2.53 EPS this Y-92.40% Inst Trans-2.73% Short Interest2.88M Perf Half Y50.06%
Book/sh25.45 P/B2.84 EPS next Y46.99% ROA-0.80% Target Price69.50 Perf Year-37.68%
Cash/sh7.91 P/C9.13 EPS next 5Y12.00% ROE-1.60% 52W Range46.11 - 125.17 Perf YTD43.28%
Dividend- P/FCF67.57 EPS past 5Y-14.60% ROI0.30% 52W High-42.29% Beta0.89
Dividend %- Quick Ratio1.70 Sales past 5Y12.70% Gross Margin45.10% 52W Low56.67% ATR2.38
Employees4230 Current Ratio2.10 Sales Q/Q-8.80% Oper. Margin-2.40% RSI (14)54.16 Volatility2.84% 3.34%
OptionableYes Debt/Eq0.00 EPS Q/Q-295.00% Profit Margin-1.40% Rel Volume0.51 Prev Close73.52
ShortableYes LT Debt/Eq0.50 EarningsMay 02 AMC Payout0.00% Avg Volume416.45K Price72.24
Recom2.00 SMA20-0.83% SMA5010.21% SMA20010.81% Volume211,803 Change-1.74%
Date Action Analyst Rating Change Price Target Change
Feb-27-23Upgrade The Benchmark Company Hold → Buy $68
Nov-03-22Downgrade The Benchmark Company Buy → Hold
Sep-16-22Initiated KeyBanc Capital Markets Overweight $130
Sep-09-22Initiated BofA Securities Buy $120
Jul-15-22Initiated SVB Leerink Mkt Perform $124
Dec-06-21Resumed Wells Fargo Overweight $203
Jun-09-21Initiated JP Morgan Neutral $146
May-24-21Initiated BTIG Research Buy $165
Feb-02-21Upgrade Piper Sandler Neutral → Overweight $86 → $147
Dec-08-20Initiated Berenberg Buy $145
Jun-01-23 03:00PM
May-30-23 04:01PM
May-18-23 01:09PM
May-15-23 04:01PM
10:51AM Loading…
May-09-23 10:51AM
May-03-23 04:01PM
May-02-23 05:15PM
May-01-23 10:15AM
Apr-26-23 08:00PM
02:00PM Loading…
Apr-20-23 02:00PM
Apr-12-23 04:27PM
Apr-11-23 12:53PM
Apr-05-23 07:04AM
Mar-31-23 05:25PM
Mar-30-23 11:30AM
Mar-29-23 12:17PM
Mar-20-23 03:04AM
Mar-17-23 06:52AM
Mar-03-23 08:11PM
Mar-01-23 09:22AM
Feb-28-23 05:25PM
Feb-27-23 05:37AM
08:01AM Loading…
Feb-24-23 08:01AM
Feb-16-23 04:01PM
Feb-15-23 11:36AM
Feb-09-23 05:00AM
Feb-08-23 10:00AM
Feb-06-23 10:00AM
Jan-19-23 07:39AM
Jan-17-23 08:30AM
Jan-16-23 07:11AM
Jan-05-23 04:01PM
Jan-04-23 07:06AM
Jan-03-23 07:01AM
Dec-29-22 09:01AM
Dec-28-22 07:22AM
Dec-21-22 11:46AM
Dec-18-22 04:43PM
Dec-08-22 09:16AM
Dec-05-22 08:01AM
Nov-23-22 04:01PM
Nov-15-22 09:49AM
Nov-09-22 05:26AM
Nov-07-22 10:16AM
Nov-04-22 04:29PM
Nov-03-22 05:13PM
Nov-02-22 12:02PM
Oct-18-22 12:04PM
Oct-13-22 04:01PM
Oct-11-22 08:01AM
Oct-05-22 11:40AM
Sep-21-22 01:41PM
Sep-20-22 04:01PM
Sep-08-22 11:37AM
Aug-31-22 04:01PM
Aug-25-22 04:05PM
Aug-10-22 02:56PM
Aug-09-22 11:40AM
Aug-04-22 05:55PM
Aug-01-22 10:01AM
Jul-28-22 10:02AM
Jul-21-22 04:59PM
Jul-14-22 08:04AM
Jul-11-22 04:05PM
Jul-06-22 11:48PM
Jul-04-22 10:29AM
Jul-01-22 10:33AM
Jun-30-22 11:14AM
Jun-29-22 01:25PM
Jun-28-22 06:28PM
Jun-27-22 11:34AM
Jun-24-22 12:31PM
Jun-23-22 12:16PM
Jun-22-22 12:24PM
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility's in-house information management systems; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based nexus of solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Santa Clara, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bauer Joanne BDirectorMar 07Option Exercise25.5319,329493,46941,211Mar 09 04:08 PM
Bauer Joanne BDirectorMar 07Sale54.2413,115711,33328,096Mar 09 04:08 PM
PARRISH MARK WDirectorDec 28Option Exercise14.873,00044,61061,459Dec 29 04:17 PM
Seidelmann Scott PeterEVP, CHIEF COMMERCIAL OFFICERDec 27Sale48.2894545,62529,788Dec 29 04:16 PM
PARRISH MARK WDirectorDec 22Option Exercise14.873,00044,61058,459Dec 22 04:53 PM
Seidelmann Scott PeterEVP, CHIEF COMMERCIAL OFFICERDec 16Sale47.794,436211,99030,733Dec 19 05:08 PM
PARRISH MARK WDirectorDec 15Option Exercise14.873,00044,61055,459Dec 19 04:48 PM
PARRISH MARK WDirectorDec 07Option Exercise14.873,00044,61052,459Dec 09 05:02 PM
LIPPS RANDALL ACHAIRMAN, PRESIDENT AND CEODec 01Option Exercise17.292,50043,22590,848Dec 05 04:50 PM
LIPPS RANDALL ACHAIRMAN, PRESIDENT AND CEODec 01Sale50.782,500126,94288,348Dec 05 04:50 PM
PARRISH MARK WDirectorNov 29Option Exercise14.871,27819,00449,459Dec 01 04:37 PM
Seidelmann Scott PeterEVP, CHIEF COMMERCIAL OFFICERNov 28Sale51.461,79392,26838,996Nov 30 05:26 PM
Kuipers Peter J.EXECUTIVE V P& CFOAug 26Option Exercise69.8815,5001,083,07976,826Aug 30 06:06 PM
Kuipers Peter J.EXECUTIVE V P& CFOAug 26Sale108.2915,5001,678,52461,326Aug 30 06:06 PM
Kuipers Peter J.EXECUTIVE V P& CFOAug 22Option Exercise44.2511,000486,75072,326Aug 24 04:27 PM
Kuipers Peter J.EXECUTIVE V P& CFOAug 22Sale105.9311,0001,165,22961,326Aug 24 04:27 PM
LIPPS RANDALL ACHAIRMAN, PRESIDENT AND CEOAug 16Sale111.0413,0001,443,478302,049Aug 18 05:29 PM
Seidelmann Scott PeterEVP, CHIEF COMMERCIAL OFFICERJun 16Sale110.153,765414,73240,789Jun 17 05:11 PM